Recurrent Pituitary Adenomas
1 clinical trials · Condition
◉ Watch Recurrent Pituitary Adenomas
| Record | Firm | Date |
|---|---|---|
| Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas (NCT03930771) | Weill Medical College of Cornell University | 2019-05-21 |
Track Recurrent Pituitary Adenomas automatically
Every clearance here is in the API, with alerts when new ones post.